311 related articles for article (PubMed ID: 33262350)
1. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
Lee CY; Cheu RK; Lemke MM; Gustin AT; France MT; Hampel B; Thurman AR; Doncel GF; Ravel J; Klatt NR; Arnold KB
Nat Commun; 2020 Dec; 11(1):6147. PubMed ID: 33262350
[TBL] [Abstract][Full Text] [Related]
2. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
3. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
4. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
5. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
6. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
7. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
[TBL] [Abstract][Full Text] [Related]
8. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
Tamarelle J; Ma B; Gajer P; Humphrys MS; Terplan M; Mark KS; Thiébaut ACM; Forney LJ; Brotman RM; Delarocque-Astagneau E; Bavoil PM; Ravel J
J Infect Dis; 2020 Feb; 221(4):627-635. PubMed ID: 31573603
[TBL] [Abstract][Full Text] [Related]
9. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.
Swidsinski A; Dörffel Y; Loening-Baucke V; Schilling J; Mendling W
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):41-6. PubMed ID: 20955467
[TBL] [Abstract][Full Text] [Related]
10. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
[TBL] [Abstract][Full Text] [Related]
12. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
[TBL] [Abstract][Full Text] [Related]
13. Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.
Mollin A; Katta M; Sobel JD; Akins RA
PLoS One; 2022; 17(7):e0272012. PubMed ID: 35901180
[TBL] [Abstract][Full Text] [Related]
14. The vaginal microbiota in the course of bacterial vaginosis treatment.
Zwittink RD; van den Munckhof EHA; Leverstein-van Hall MA; Boers K; Molijn A; Knetsch CW; Kuijper EJ
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):651-656. PubMed ID: 33029765
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
Nagaraja P
Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
[TBL] [Abstract][Full Text] [Related]
16. Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis.
Mayer BT; Srinivasan S; Fiedler TL; Marrazzo JM; Fredricks DN; Schiffer JT
J Infect Dis; 2015 Sep; 212(5):793-802. PubMed ID: 25676470
[TBL] [Abstract][Full Text] [Related]
17. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.
Cruciani F; Biagi E; Severgnini M; Consolandi C; Calanni F; Donders G; Brigidi P; Vitali B
Antimicrob Agents Chemother; 2015 May; 59(5):2825-34. PubMed ID: 25733514
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility to antibiotics of microorganisms related with recurrent bacterial vaginosis].
Shopova E; Nikolov A; Dimitrov A
Akush Ginekol (Sofiia); 2011; 50(7):20-1. PubMed ID: 22452174
[TBL] [Abstract][Full Text] [Related]
19. Deep sequencing of the vaginal microbiota of women with HIV.
Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
Tomusiak A; Strus M; Heczko PB
Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
